NASDAQ:IFRX - InflaRx N.V.
$33.22
 $2.06
+6.61%
2:45PM EDT
2019-02-15
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IFRX     avg for
industry  
  avg for
sector  
42 stocks weight:  68. 26   0. 01   3. 19  
42 stocks rank:  2. 30 K 2. 01 K 1. 09 K
# analyst opinions:  7. 00   14. 84   14. 43  
mean recommendation:  1. 70   1. 91   1. 90  

quick ratio:  18. 54   5. 33   1. 80  
current ratio:  18. 68   5. 64   2. 19  

target price low:  41. 51   89. 87   116. 44  
target price avg:  47. 30   116. 13   140. 62  
target price high:  61. 27   144. 13   161. 60  
1-yr high:  41. 46   124. 91   142. 18  
last close:  33. 65   101. 33   125. 34  
50-day avg:  31. 64   98. 45   122. 34  
200-day avg:  32. 72   99. 87   122. 31  
1-yr low:  23. 33   77. 93   99. 86  
volume:  22. 39 K 2. 40 M 4. 39 M
50-day avg volume:  72. 33 K 3. 29 M 4. 86 M
200-day avg volume:  43. 81 K 3. 21 M 4. 16 M

1-day return:  2. 22 % 0. 35 % -0. 08 %
this week return:  2. 22 % 0. 46 % -0. 07 %
12-wk return:  12. 62 % 5. 59 % 1. 56 %
52-wk return:  22. 19 % -0. 88 % 14. 91 %

enterprise value (EV):  873. 28 M 54. 52 B 102. 18 B
market cap:  863. 55 M 48. 30 B 93. 12 B

shares outstanding:  25. 66 M 601. 87 M 1. 19 B
shares:  7. 13 M 599. 22 M 1. 12 B
shares short:  289. 21 K 11. 51 M 12. 17 M
shares short prior month:  245. 08 K 11. 81 M 13. 15 M
short ratio:  3. 10   4. 63   2. 90  
short % of float:  1. 63 % 6. 17 % 2. 78 %

book value:  7. 20   14. 36   28. 94  
price/book:  4. 67   -1. 54   -2. 98  
operating margins:  0. 00 % -468. 22 % -616. 90 %
EBITDA margins:  0. 00 % 13. 04 % 22. 45 %
profit margins:  0. 00 % 6. 01 % 9. 83 %
gross margins:  0. 00 % 48. 26 % 54. 52 %

1-yr max volatility:  18. 51 % --- ---
1-yr mean volatility:  0. 22 % 0. 02 % 0. 07 %

1-yr EPS:  -1. 39   2. 91   4. 09  
forward EPS:  -2. 11   4. 19   6. 88  
P/E:  -24. 26   4. 76   27. 05  
forward P/E:  -15. 88   7. 25   10. 02  
PE/G:  21. 43   1. 60   5. 54  
growth:  -1. 13 % 630. 40 % 97. 64 %
earnings high:  -0. 26   1. 24   1. 63  
earnings avg:  -0. 41   0. 98   1. 51  
earnings low:  -0. 54   0. 73   1. 38  
revenue high:  90. 00 K 2. 84 B 10. 79 B
revenue avg:  20. 00 K 2. 75 B 10. 45 B
revenue low:  -0. 00   2. 64 B 10. 25 B
return on assets:  -22. 90 % -3. 52 % 3. 78 %
return on equity:  -51. 05 % 105. 21 % 25. 65 %

beta (1yr vs S&P500):  0. 72   1. 22   0. 94  
sharpe (1yr):  0. 87   0. 20   1. 02  

held % insiders:  44. 16 % 6. 52 % 3. 28 %
held % institutions:  59. 65 % 79. 51 % 70. 64 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-11 : IFRX
.    + 4.414 =         4.414 :: INITIAL WEIGHT
.  + 234.063 =       238.477 :: inverse volume-to-price addition
.  + 351.013 =        589.49 :: spline projection addition
.   - 134.78 =        454.71 :: poor performance penalty
.    x 1.432 =       651.106 :: one-year gains+dividend factor
.    x 2.058 =      1339.676 :: 13 weeks' performance factor
.    x 1.494 =      2000.927 :: industry recommendation factor
.    x 2.622 =      5247.014 :: symbol recommendation factor
.    x 0.998 =      5234.997 :: return on assets factor
.    x 0.995 =      5208.272 :: return on equity factor
.    x 3.485 =     18151.187 :: current ratio factor
.    x 1.028 =     18661.466 :: quick ratio factor
.     x 1.15 =      21461.34 :: short ratio factor
.    x 2.047 =     43925.979 :: price-to-book factor
.    x 1.031 =     45299.987 :: 5-day avg > 200-day avg
.    x 1.066 =     48306.243 :: 5-day avg > 50-day avg
.    x 2.158 =    104255.363 :: P/E weight
.    x 0.465 =     48456.248 :: PE/G factor
.    x 1.524 =     73844.789 :: beta factor
.    x 0.874 =     64560.036 :: sharpe factor
.    x 1.501 =     96932.614 :: target low factor
.    x 1.212 =    117511.529 :: target mean factor
.    x 1.091 =    128157.855 :: target high factor
.    x 1.056 =    135320.604 :: industry 12-weeks return
.    x 0.988 =    133631.244 :: "drift" penalty 1 days ago
.    x 0.998 =    133329.996 :: overall "drift" factor
.    x 0.851 =    113402.055 :: largest single-day jump factor
.     x 1.01 =     114533.54 :: mean volatility factor
.    x 1.096 =    125570.618 :: 42-day mean volatility factor
.      x 1.0 =    125577.931 :: factor hist industry gain for week 06
.   cubeRoot =        50.077 :: reduced for readability
.                     50.077 :: FINAL WEIGHT for NASDAQ:IFRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org